Evidence map›Paper›PMID 36757551›Full record

ReviewMolecular biology reports2023

Zebrafish, a biological model for pharmaceutical research for the management of anxiety.

Amir Modarresi Chahardehi, Yasaman Hosseini, Seyed Mohammad Mahdavi, Iman Naseh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Varivax (IBRO neuroscience reports · 2026
    Article
  2. Isothiocyanate-Rich Essential Oil ofPlants (Basel, Switzerland) · 2026
    Article
  3. Microplastic Exposure Disrupts Energy Homeostasis and Welfare in Goldfish.Animals : an open access journal from MDPI · 2026
    Article
  4. Article
  5. Zebrafish (Biology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Amir Modarresi ChahardehiCognitive Neuroscience Research Center, AJA University of Medical Sciences, Tehran, Iran. amirmch@gmail.com.ORCID http://orcid.org/0000-0002-9767-6255
Yasaman HosseiniCognitive Neuroscience Research Center, AJA University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-7524-3301
Seyed Mohammad MahdaviDepartment of Bioscience and Biotechnology, Malek Ashtar University of Technology (MUT), Tehran, Iran. sm_mahdavi@mut.ac.ir.
Iman NasehCognitive Neuroscience Research Center, AJA University of Medical Sciences, Tehran, Iran.
Aja University of Medical Sciences · IRMalek Ashtar University of Technology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The zebrafish (Danio rerio) is a valuable animal model rapidly becoming more commonly used in pharmaceutical studies. Due to its low-cost maintenance and high breeding potential, the zebrafish is a suitable substitute for most adult rodents (mice and rats) in neuroscience research. It is widely used in various anxiety models. This species has been used to develop a conceptual framework for anxiety behavior studies with broad applications in the laboratory, including the study of herbal and chemical drugs. This review discusses the latest studies of anxiety-related behavior in the zebrafish model.

Indexed as

Pharmaceutical ResearchZebrafishAnimalsAnxietyBehavior, AnimalDisease Models, AnimalMiceRatsAnxiety disordersBehavioral testsNeuroscienceZebrafish

Identifiers

PMID36757551
OpenAlexW4319656269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.